Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.

NCT00276003 is registered in ClinicalTrials.gov with University of New Mexico as lead sponsor.

NCT NCT00276003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00276003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
Lead sponsor
University of New Mexico
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2002
Completion date
August 31, 2005
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, non-hodgkin's lymphoma